Description

Haloperidol is a potent butyrophenone-class antipsychotic agent, widely recognized for its critical role in modern psychiatric medicine. Its primary value lies in its high efficacy in managing psychotic disorders, severe agitation, and Tourette syndrome, making it a cornerstone in both acute and long-term treatment protocols. This active pharmaceutical ingredient (API) is essential for manufacturers of generic and branded injectable solutions, oral tablets, and other dosage forms targeting neurological and psychiatric conditions. Global pharmaceutical companies and contract manufacturing organizations (CMOs) rely on a consistent, high-purity supply to ensure the safety and efficacy of their final drug products.

Application

• Pharmaceutical API: Primary use as the active ingredient in the manufacture of antipsychotic medications.
• Injectable Formulations: Used in the production of fast-acting intramuscular or intravenous solutions for acute agitation and psychosis.
• Oral Solid Dosages: Incorporated into tablets and liquid concentrates for the maintenance therapy of schizophrenia and related disorders.
• Neurological Research: Serves as a standard dopamine D2 receptor antagonist in preclinical and clinical neurological studies.
• Generic Drug Production: A key component for companies developing bioequivalent versions of established antipsychotic drugs.
• Hospital & Clinical Formulary: Essential for compounding pharmacies and hospital procurement for emergency and routine care.

Basic Information

Product Name	Haloperidol
CAS No.	52-86-8
Molecular Formula	C21H23ClFNO2
Molecular Weight	375.87 g/mol
Synonyms	4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; Haldol; Aloperidin; Serenace; R-1625; Haloperidolum; Haloperidol Base; Haloperidol API
EINECS	200-160-4

Quality Control

Our Haloperidol is manufactured under strict quality management systems, targeting compliance with major pharmacopoeial standards such as USP, EP, and BP. Every batch undergoes comprehensive analytical testing including identification, assay, impurity profiling, and residual solvent analysis to ensure it meets stringent pharmaceutical-grade specifications. A Certificate of Analysis (COA) documenting purity, related substances, and other critical parameters is provided with each shipment to guarantee traceability and regulatory compliance for our global B2B clients.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature, 15-25°C (59-77°F). The product is light-sensitive and should be handled and stored accordingly to maintain stability and potency.

Specification

Item	Specification
Appearance	White or almost white crystalline powder
Identification (IR)	Conforms to standard
Identification (HPLC)	Conforms to standard
Assay (HPLC)	98.0% - 102.0% (on dried basis)
Loss on Drying	≤ 0.5%
Related Substances (HPLC)	Individual impurity: ≤ 0.1% Total impurities: ≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.